Shortage outlook · by company · read 11 November 2026
Which drugs does Somerset Therapeutics, LLC have on the FDA shortage list?
Somerset Therapeutics, LLC has 25 presentations of 6 drugs on the FDA shortage list, 5 of them reported unavailable. Each is the company's own report to the FDA, with the date of its last update. A report is the company's statement, not a check of any pharmacy's stock.
Somerset Therapeutics, LLC has 25 presentations of 6 drugs on the FDA shortage list in 11 November 2026.
The company reported 20 available, 0 with limited availability and 5 unavailable.
Drug by drug, as the company reported it
- Bupivacaine Hydrochloride6 presentations · on the list 8 years and 8 months · last updated 27 October 2026
- Ropivacaine Hydrochloride10 presentations · on the list 8 years and 7 months · last updated 27 October 2026
- Atropine Sulfate3 presentations · on the list 12 years and 5 months · last updated 27 October 2026
- Dexamethasone Sodium Phosphate2 presentations · on the list 7 years and 6 months · last updated 27 October 2026
- Dexmedetomidine Hydrochloride2 presentations · on the list 6 years and 6 months · last updated 27 October 2026
- Sodium Acetate2 presentations · on the list 10 years and 8 months · last updated 27 October 2026
FDA current shortage listing file, read 11 November 2026. Availability is the company's own statement to the FDA, not a check of any pharmacy's stock.
Where can you go from here?
Look up any medicine to see how long it has been listed and every company that reports it. The FDA explains what a listing means in the FDA's frequently asked questions about drug shortages, and the list itself is the FDA drug shortages database.